Inovio Pharma (INO) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.11 --0%
EPS Growth %: +60.7%
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +60.7%
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $12.54 million versus the consensus estimate of $5.16 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
- Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
